1.14.13.230	F321Y	mutation in subunit BmoX towards soluble methane monooxygenase, no formation of butan-2-ol	738517	
1.14.13.230	F321Y	mutation in the alpha-subunit of hydrolase component, in presence of 10 mM propanoate, 61% residual activity	-, 739008	
1.14.13.230	G113N	mutation in subunit BmoX towards soluble methane monooxygenase, ratio of 2-butanol to 1-butanol accumulation increases from 0.04 for wild-type to 11.1	738517	
1.14.13.230	G113N	mutation in the alpha-subunit of hydrolase component, loss of inhibition by propanoate	-, 739008	
1.14.13.230	L279F	mutation in subunit BmoX towards soluble methane monooxygenase, ratio of 2-butanol to 1-butanol accumulation increases from 0.04 for wild-type to 0.22	738517	
1.14.13.230	L279F	mutation in the alpha-subunit of hydrolase component, in presence of 10 mM propanoate, 56% residual activity	-, 739008	
1.14.13.230	L287F	mutation in subunit BmoX, loss of activity	738517	
1.14.13.230	P179K	mutation in subunit BmoX, loss of activity	738517	
1.14.13.230	Q319G	mutation in subunit BmoX, loss of activity	738517	
1.14.13.230	Q320K	mutation in subunit BmoX towards soluble methane monooxygenase, ratio of 2-butanol to 1-butanol accumulation increases from 0.04 for wild-type to 0.20	738517